The Possible Role of Tumor Necrosis Factor‐α in Diabetic Polyneuropathy
Author(s) -
Jo Satoh,
Soroku Yagihashi,
Takayoshi Toyota
Publication year - 2003
Publication title -
journal of diabetes research
Language(s) - English
Resource type - Journals
eISSN - 2314-6753
pISSN - 2314-6745
DOI - 10.1155/edr.2003.65
Subject(s) - polyneuropathy , medicine , tumor necrosis factor alpha , necrosis , cancer research , cardiology , oncology
In this review, the authors provide evidences that imply the role of tumor necrosis factor-alpha (TNF-alpha) in the pathogenesis of diabetic complications, especially diabetic polyneuropathy. Under chronic hyperglycemia, endogenous TNF-alpha production is accelerated in microvascular and neural tissues, which may undergo an increased microvascular permeability, hypercoagulability, and nerve damage, thus initiating and promoting the development of characteristic lesions of diabetic microangiopathy and polyneuropathy. Enhanced TNF-alpha production may also promote atherosclerosis due to increased insulin resistance and the expression of adhesion molecules. Clinical application of specific agents that suppress production and/or activity of TNF-alpha may inhibit the development and exacerbation of chronic diabetic complications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom